CCP
Corient Capital Partners’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $14.7M | Hold |
96,108
| – | – | 1.1% | 12 |
|
2022
Q2 | $14.7M | Buy |
96,108
+191
| +0.2% | +$29.3K | 1.12% | 12 |
|
2022
Q1 | $15.5M | Buy |
95,917
+6,576
| +7% | +$1.07M | 1.03% | 13 |
|
2021
Q4 | $12.1M | Buy |
89,341
+2,985
| +3% | +$404K | 0.8% | 19 |
|
2021
Q3 | $9.32M | Sell |
86,356
-3,200
| -4% | -$345K | 0.68% | 28 |
|
2021
Q2 | $10.1M | Buy |
89,556
+13,799
| +18% | +$1.55M | 0.74% | 22 |
|
2021
Q1 | $8.2M | Buy |
75,757
+1,961
| +3% | +$212K | 0.7% | 23 |
|
2020
Q4 | $7.91M | Buy |
73,796
+4,092
| +6% | +$438K | 0.79% | 25 |
|
2020
Q3 | $6.11M | Buy |
69,704
+1,130
| +2% | +$99K | 0.7% | 34 |
|
2020
Q2 | $6.73M | Buy |
68,574
+13,243
| +24% | +$1.3M | 0.82% | 24 |
|
2020
Q1 | $4.22M | Buy |
55,331
+13,187
| +31% | +$1M | 0.66% | 37 |
|
2019
Q4 | $3.73M | Buy |
42,144
+1,626
| +4% | +$144K | 0.47% | 50 |
|
2019
Q3 | $3.07M | Buy |
40,518
+833
| +2% | +$63.1K | 0.43% | 55 |
|
2019
Q2 | $2.89M | Sell |
39,685
-1,520
| -4% | -$111K | 0.44% | 50 |
|
2019
Q1 | $3.32M | Sell |
41,205
-10,616
| -20% | -$856K | 0.54% | 41 |
|
2018
Q4 | $4.78M | Sell |
51,821
-12,875
| -20% | -$1.19M | 0.85% | 18 |
|
2018
Q3 | $6.12M | Hold |
64,696
| – | – | 1.02% | 9 |
|
2018
Q2 | $5.99M | Buy |
64,696
+2,574
| +4% | +$238K | 1.05% | 8 |
|
2018
Q1 | $5.88M | Sell |
62,122
-16,551
| -21% | -$1.57M | 1.08% | 11 |
|
2017
Q4 | $7.61M | Sell |
78,673
-17,008
| -18% | -$1.64M | 1.29% | 6 |
|
2017
Q3 | $8.5M | Sell |
95,681
-8,436
| -8% | -$750K | 1.61% | 6 |
|
2017
Q2 | $7.55M | Sell |
104,117
-1,514
| -1% | -$110K | 1.16% | 11 |
|
2017
Q1 | $6.88M | Buy |
105,631
+21,349
| +25% | +$1.39M | 1.07% | 15 |
|
2016
Q4 | $5.28M | Sell |
84,282
-7,674
| -8% | -$481K | 0.93% | 16 |
|
2016
Q3 | $5.8M | Buy |
+91,956
| New | +$5.8M | 1.07% | 11 |
|